Personas / Equipo Humano

Marta Díaz Silva

Buscador de publicaciones

Publicaciones

  • de Zegher F, Sebastiani G, Díaz-Silva M, Gómez-Roig MD, López-Bermejo A and Ibañez-Toda L.

    Breast-feeding vs Formula-feeding for Infants Born Small-for-Gestational-Age: Divergent Effects on Fat Mass and on Circulating IGF-I and High-Molecular-Weight Adiponectin in Late Infancy

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 98(3): 1242-1247. Nº de citas: 35

    [doi:10.1210/jc.2012-3480]

  • Vanky E, DE Zegher F, Díaz-Silva M, Ibañez-Toda L and Carlsen SM.

    On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome - an epi-analysis

    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA . 91(12): 1460-1464. Nº de citas: 30

    [doi:10.1111/aogs.12015]

  • Díaz-Silva M, Chacón MR, López-Bermejo A, Maymó-Masip E, Salvador C, Vendrell J, de Zegher F and Ibañez-Toda L.

    Ethinyl Estradiol-Cyproterone Acetate Versus Low-Dose Pioglitazone-Flutamide-Metformin for Adolescent Girls with Androgen Excess: Divergent Effects on CD163, TWEAK Receptor, ANGPTL4, and LEPTIN Expression in Subcutaneous Adipose Tissue

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 97(10): 3630-3638. Nº de citas: 15

    [doi:10.1210/jc.2012-1754]

  • de Zegher F, Sebastiani G, Díaz-Silva M, Sánchez-Infantes D, Lopez-Bermejo A and Ibañez-Toda L.

    Body Composition and Circulating High-Molecular-Weight Adiponectin and IGF-I in Infants Born Small for Gestational Age

    Diabetes . 61(8): 1969-1973. Nº de citas: 47

    [doi:10.2337/db11-1797]

  • Díaz-Silva M, Bassols J, López-Bermejo A, Gómez-Roig MD, de Zegher F and Ibañez-Toda L.

    Placental Expression of Peroxisome Proliferator-Activated Receptor ? (PPAR?): Relation to Placental and Fetal Growth

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 97(8): 1468-1472. Nº de citas: 46

    [doi:10.1210/jc.2012-1064]

  • de Zegher F, Díaz-Silva M, Sebastiani G, Martín-Ancel A, Sánchez-Infantes D, López-Bermejo A and Ibañez-Toda L.

    Abundance of Circulating Preadipocyte Factor 1 in Early Life

    Diabetes Care . 35(4): 848-849. Nº de citas: 29

    [doi:10.2337/dc11-1990]

  • Sebastiani G, Díaz-Silva M, López-Bermejo A, Arranz A, de Zegher F and Ibañez-Toda L.

    Circulating follistatin in the human foetus at term birth

    PEDIATRIC OBESITY . 7(1): 39-43. Nº de citas: 7

    [doi:10.1111/j.2047-6310.2011.00004.x]

  • Vinaixa M, Rodriguez MA, Samino S, Díaz-Silva M, Beltran A, Mallol R, Bladé C, Ibañez-Toda L, Correig X and Yanes O.

    Metabolomics Reveals Reduction of Metabolic Oxidation in Women with Polycystic Ovary Syndrome after Pioglitazone-Flutamide-Metformin Polytherapy

    PLoS One . 6(12): . Nº de citas: 53

    [doi:10.1371/journal.pone.0029052]

  • Lázaro I, Díaz-Silva M, Cabré A, Masana L and Ibañez-Toda L.

    Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess

    GYNECOLOGICAL ENDOCRINOLOGY . 27(11): 935-939. Nº de citas: 12

    [doi:10.3109/09513590.2011.569608]

  • Ibañez-Toda L, Díaz-Silva M, Sebastiani G, Sánchez-Infantes D, Salvador C, Lopez-Bermejo A and de Zegher F.

    Treatment of Androgen Excess in Adolescent Girls: Ethinylestradiol-Cyproteroneacetate Versus Low-Dose Pioglitazone-Flutamide-Metformin

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 96(11): 3361-3366. Nº de citas: 30

    [doi:10.1210/jc.2011-1671]